Navigation Links
Little Relief for Leprosy Patients from the Government

India may be hailed as a leprosy-free zone by health administrators worldwide. But the bitter fact is that over a thousand and more are suffering// from the terrifying disease.

But public health efforts to treat them have been inadequate, many point out. And the stigma the disease carries with it makes the patients’ lives completely miserable.

Leprosy is an ancient, much feared disease. But although it is infectious and spreads like tuberculosis, it is very hard to catch.

Still it is eminently curable. Besides most people are believed to have some natural immunity to the germ responsible.

It is estimated that in the past 20 years, 15 million people worldwide have been cured of leprosy, a majority of them in India.

Recently India announced it had "eliminated" leprosy. But then elimination simply means there is now fewer than one case in every 10,000 persons. Given India's vast population, this means there are more than a 150,000 new cases each year.

Worse there is so much stigma attached to the disease that even after being cured of leprosy, chances of integrating with the mainstream are slim. So they all tend to live together in their own ghettoes. Today there are more than 1,000 leprosy colonies in India, it is said. And most leprosy patients survive by begging.

India has stopped actively searching for leprosy cases. Instead it now expects communities to recognise the disease and do what they can to mitigate the problem. That is a very disturbing trend, say activists.

Indications are that leprosy could continue to disfigure and disable Indians well into the 21st Century.
GPL
'"/>




Page: 1

Related medicine news :

1. Little sleep as bad as no sleep
2. Aspirin Induced Asthma , A Little-Known Inducer
3. A Little Weight Loss Found To Make A Significant Difference In Men
4. Little Known DNA Repair Enzyme May Be A Tumor Suppressor Gene
5. Little Clinic LLC Plans Super Medical Clinics in Publix Super Markets
6. Trendsetters: Little girls fast track into ladies even before they know it
7. The Little Known Facts of Junk DNA
8. Too Much Or Little Sleep Increases Risk Of Diabetes
9. Diabetes Risk Pronounced With Too Much or Too Little Sleep
10. Reverse Heart Transplant Surgery On A Little Girl Makes History
11. Most People With Arthritis Do Little Or No Exercise At All
Post Your Comments:
Breaking Medicine News(10 mins):Health News:Senator Ben Nelson Puts U.S. Bishops' Interests Ahead of Americans' Healthcare Needs 2Health News:Patriot Scientific Corporation Announces New Director 2Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 2Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 3Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 4Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 5Health News:Lilly Announces the First 300-unit Vial of Insulin 2Health News:Lilly Announces the First 300-unit Vial of Insulin 3Health News:Lilly Announces the First 300-unit Vial of Insulin 4Health News:Health Care Without Harm Applauds EPA Finding Climate Change is Danger to Public Health 2Health News:Health Care Without Harm Applauds EPA Finding Climate Change is Danger to Public Health 3
Breaking Medicine Technology:ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 2ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 3ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 5ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 6ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 7FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 2FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5New iPhone Application for Anesthesiologists 51079 1New iPhone Application for Anesthesiologists 51079 2BullMarket com Updates Outlook on Healthcare IT Stocks 51074 1BullMarket com Updates Outlook on Healthcare IT Stocks 51074 2Health Caregivers and Allies to Rally 5 p m Weds in Fremont 51070 1Health Caregivers and Allies to Rally 5 p m Weds in Fremont 51070 2